SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001800934-20-000002
Filing Date
2020-01-23
Accepted
2020-01-23 14:25:46
Documents
1
Effectiveness Date
2020-01-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4755
  Complete submission text file 0001800934-20-000002.txt   5780
Mailing Address 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address 953 INDIANA STREET SAN FRANCISCO CA 94107 217-766-4292
Revel Pharmaceuticals Inc. (Filer) CIK: 0001800934 (see all company filings)

IRS No.: 842338101 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-358789 | Film No.: 20541533